Get the Stockscreener App
23.88
1.34%
-0.3243
T. Rowe Price Biotech ETF Stock (TDNA) Forecast
The T. Rowe Price Biotech ETF (TDNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $23.31, representing a -2.37% decrease from the current price of $23.88. The highest analyst price target is $24.36, and the lowest is $22.26.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TDNA Price Target
Average 19.55
(-18.10% Downside)
Is T. Rowe Price Biotech ETF (TDNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.91 | Neutral |
| STOCH(9,6) | 25.13 | Neutral |
| STOCHRSI(14) | 0.00 | Neutral |
| MACD(12,26) | 0.00 | Neutral |
| ADX(14) | 0.00 | Neutral |
| William %R | -65.20 | Neutral |
| CCI(14) | -5.8778 | Neutral |
Buy: 0
Sell: 0
Neutral: 7
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
24.37
Sell
|
24.26
Sell
|
| MA20 |
22.19
Buy
|
0.00
Buy
|
| MA50 |
8.8742
Buy
|
0.00
Buy
|
| MA100 |
4.4371
Buy
|
0.00
Buy
|
| MA200 |
2.2185
Buy
|
0.00
Buy
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, TDNA could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 2 signaling Sell signals and 7 Neutral signals. This might be a good time to open fresh positions on TDNA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 36.91 indicates that TDNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.13 indicates that TDNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that TDNA is oversold. This suggests that TDNA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -5.8778 indicates that TDNA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TDNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about T. Rowe Price Biotech ETF financial reports and earnings history, T. Rowe Price Biotech ETF (TDNA) stock could reach $1.324 by 2030, $81.45 by 2040 and $162.34 by 2050. See the projected annual prices until 2050 of the T. Rowe Price Biotech ETF stock below:
- T. Rowe Price Biotech ETF (TDNA) is expected to reach an average price of $41.22 in 2035, with a high prediction of $41.38 and a low estimate of $41.22. This indicates an $72.63% rise from the last recorded price of $23.88.
- T. Rowe Price Biotech ETF (TDNA) stock is projected to chart a bullish course in 2040, with an average price target of $80.24, representing an $236.07% surge from its current level. The forecast ranges from a conservative $80.54 to a sky-high $81.45.
- Our analysts predict T. Rowe Price Biotech ETF (TDNA) to jump 414.92% by 2045, soaring from $119.86 to an average price of $122.95, potentially reaching $122.28. While $119.86 is the low estimate, the potential upside is significant.
- T. Rowe Price Biotech ETF (TDNA) stock is expected to climb by 2050, reaching an average of $162.33, a $579.89% jump from its current level. However, a wide range of estimates exists, with high and low targets of $162.34 and $159.18, respectively, highlighting the market's uncertainty.
T. Rowe Price Biotech ETF Stock (TDNA) Year by Year Forecast
T. Rowe Price Biotech ETF Stock (TDNA) Price Forecast for 2026
The predicted value for T. Rowe Price Biotech ETF (TDNA) in 2026 is set at an average of $23.59. Estimates vary from a peak of $25.68 to a trough of $21.51, indicating an -1.18% surge from the present price of $23.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $23.62 | $22.26 | $24.36 | -1.07% |
| December, 2026 | $22.19 | $21.51 | $23.61 | -7.08% |
T. Rowe Price Biotech ETF Stock (TDNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for T. Rowe Price Biotech ETF (TDNA) is $18.56, with a high forecast of $23.13 and a low forecast of $13.99. This indicates an -22.27% decrease from the last price of $23.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.89 | $20.76 | $23.13 | -8.32% |
| February, 2027 | $21.20 | $20.00 | $22.62 | -11.23% |
| March, 2027 | $20.44 | $19.25 | $21.85 | -14.38% |
| April, 2027 | $20.03 | $19.82 | $21.09 | -16.11% |
| May, 2027 | $19.27 | $18.50 | $20.47 | -19.28% |
| June, 2027 | $19.06 | $17.75 | $19.72 | -20.19% |
| July, 2027 | $17.59 | $17.00 | $19.07 | -26.32% |
| August, 2027 | $16.83 | $16.25 | $18.56 | -29.53% |
| September, 2027 | $16.50 | $15.50 | $17.80 | -30.91% |
| October, 2027 | $15.94 | $14.74 | $17.26 | -33.26% |
| November, 2027 | $15.18 | $13.99 | $16.49 | -36.41% |
| December, 2027 | $14.74 | $14.46 | $15.73 | -38.28% |
T. Rowe Price Biotech ETF Stock (TDNA) Price Forecast for 2028
In 2028, T. Rowe Price Biotech ETF (TDNA) is projected to reach an average price of $10.47, with a high projection of $15.21 and a low estimate of $5.7281. This indicates an -56.15% fall from the last price of $23.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.98 | $13.24 | $15.21 | -41.45% |
| February, 2028 | $13.73 | $12.49 | $14.46 | -42.50% |
| March, 2028 | $12.23 | $11.74 | $13.78 | -48.77% |
| April, 2028 | $11.87 | $10.99 | $13.24 | -50.27% |
| May, 2028 | $11.10 | $10.24 | $12.66 | -53.49% |
| June, 2028 | $10.68 | $9.4851 | $11.90 | -55.29% |
| July, 2028 | $9.9245 | $8.7337 | $11.13 | -58.43% |
| August, 2028 | $9.4429 | $9.0971 | $10.37 | -60.45% |
| September, 2028 | $9.1644 | $7.9823 | $9.9523 | -61.62% |
| October, 2028 | $8.4035 | $7.2309 | $9.2411 | -64.80% |
| November, 2028 | $6.8732 | $6.4795 | $8.4849 | -71.21% |
| December, 2028 | $6.4816 | $5.7281 | $7.9095 | -72.85% |
T. Rowe Price Biotech ETF Stock (TDNA) Price Forecast for 2029
The 2029 price forecast for T. Rowe Price Biotech ETF Stock (TDNA) is $3.6976 on average, with a high prediction of $7.3045 and a low estimate of $0.0907. This represents an -84.51% decrease from the previous price of $23.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.7112 | $4.9767 | $7.3045 | -76.08% |
| February, 2029 | $5.4162 | $4.2254 | $6.5388 | -77.32% |
| March, 2029 | $4.9061 | $4.5032 | $5.7732 | -79.45% |
| April, 2029 | $4.1499 | $3.474 | $5.444 | -82.62% |
| May, 2029 | $3.8381 | $2.7226 | $4.6926 | -83.93% |
| June, 2029 | $2.2794 | $1.9712 | $3.9481 | -90.45% |
| July, 2029 | $1.5137 | $1.2198 | $3.3441 | -93.66% |
| August, 2029 | $1.0888 | $0.4684 | $2.5832 | -95.44% |
| September, 2029 | $0.9078 | $0.283 | $1.945 | -96.20% |
| October, 2029 | $0.1565 | $0.0907 | $1.1793 | -99.34% |
| November, 2029 | $0.3869 | $0.3869 | $0.4137 | -98.38% |
| December, 2029 | $1.143 | $1.143 | $0.5887 | -95.21% |
T. Rowe Price Biotech ETF Stock (TDNA) Price Forecast for 2030
T. Rowe Price Biotech ETF Stock (TDNA) is expected to reach an average price of $5.4636 in 2030, with a high forecast of $9.028 and a low forecast of $1.8992. This signifies an -77.12% decrease from the last price of $23.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4881 | $1.9758 | $1.324 | -93.77% |
| February, 2030 | $3.0802 | $1.8992 | $2.0944 | -87.10% |
| March, 2030 | $3.5336 | $2.6553 | $2.8648 | -85.20% |
| April, 2030 | $4.304 | $3.4114 | $3.6352 | -81.97% |
| May, 2030 | $4.3519 | $4.1676 | $3.6133 | -81.77% |
| June, 2030 | $4.9237 | $4.9237 | $4.4056 | -79.38% |
| July, 2030 | $5.6799 | $5.6799 | $5.176 | -76.21% |
| August, 2030 | $6.0535 | $6.5412 | $5.9464 | -74.65% |
| September, 2030 | $6.8144 | $6.436 | $6.7168 | -71.46% |
| October, 2030 | $8.4397 | $7.1921 | $7.4872 | -64.65% |
| November, 2030 | $8.9264 | $7.9483 | $8.2576 | -62.61% |
| December, 2030 | $9.6968 | $8.7044 | $9.028 | -59.39% |
0.17%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):